Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ARGX stock hub

argenx SE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ARGXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

49.1B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ARGX

In the news

Latest news · ARGX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25

P25 12.3P50 18.4P75 33.1

Trailing P/E33

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROIC44.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ARGX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

196

Groups with data

Currency

USD

Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001697862
Company name	argenx SE
Country	Netherlands
Country code	US
Cusip	04016X101
Employees	1,863
Employees Change	264%
Employees Change Percent	16.51
Enterprise value	$44.6B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2017-05-18
Isin	US04016X1019
Last refreshed	2026-05-10
Market cap	$49.1B
Market cap category	Large-Cap
Price	$782
Price currency	USD
Rev Per Employee	2,545,608.7x
Sector	Healthcare
Sic	2836
Symbol	ARGX
Website	https://argenx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.03%
EV Earnings	29.96x
EV Sales Forward	6.84x
EV/EBIT	34.07x
EV/EBITDA	33.84x
EV/Sales	9.41x
Forward P/E	25.02x
P/B ratio	6.7x
P/E ratio	32.97x
P/S ratio	10.35x
PS Forward	7.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.61%
EBITDA Margin	27.8%
Gross margin	58.11%
Gross Profit	$2.8B
Gross Profit Growth	110.26%
Gross Profit Growth Q	79.4%
Net Income	$1.5B
Net Income Growth	39.93%
Net Income Growth Q	115.97%
Net Income Growth Years	3%
Pretax Margin	31.68%
Profit Margin	31.4%
Profit Per Employee	$799,267
Profitable Years	2
Roa5y	-4.42
Roe5y	-3.39
ROIC	44.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	25.58%
Cagr3y	24.61%
Cagr5y	24.29%
EPS Growth	41.13
EPS Growth Q	114
EPS Growth Years	3
Revenue Growth	79.43x
Revenue Growth Q	62.63x
Revenue Growth Years	0x
Revenue Growth3 Y	95.02x
Revenue Growth5 Y	87.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	$4.4B
Debt	$47.2M
Debt EBITDA	$0.04
Debt Equity	$0.01
Equity	$7.3B
Interest Coverage	412.5
Net Cash	$4.4B
Net Cash By Market Cap	$8.95
Net Cash Growth	31.53%
Net Debt EBITDA	$-3.33
Net Debt Equity	$-0.6
Tangible Book Value	$7.1B
Tangible Book Value Per Share	$114
WACC	3.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.85%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	25.56%
200-day SMA	786
3Y total return	93.53%
50-day SMA	756.7
50-day SMA vs 200-day SMA	50under200
5Y total return	196.61%
All Time High	934.6
All Time High Change	-16.31%
All Time High Date	2025-12-03
All Time Low	17.33
All Time Low Change	4,413.39%
All Time Low Date	2017-05-18
ATR	23.12
Beta	-0.06
Ch YTD	-6.99
High	792
High52	934.6
High52 Date	2025-12-03
High52ch	-16.31%
Low	778.1
Low52	510.1
Low52 Date	2025-06-30
Low52ch	53.35%
Ma50ch	3.37%
Premarket Change Percent	0.1
Premarket Price	$788
Premarket Volume	1,878
Price vs 200-day SMA	-0.49%
RSI	49.01
RSI Monthly	61.19
RSI Weekly	50.49
Sharpe ratio	0.76x
Sortino ratio	1.36
Total Return	0.85%
Tr YTD	-6.99
Tr1m	2.19%
Tr1w	-0.17%
Tr3m	-3.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	19
Analyst Count Top	11
Analyst Price Target Top	$1,018
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$4.39
Earnings EPS Estimate Growth	70.16
Earnings Revenue Estimate	1,156,072,488x
Earnings Revenue Estimate Growth	43.2x
Operating Income	$1.3B
Operating Income Growth	509
Operating Income Growth Q	178.9
Operating margin	27.61
Price target	$1,010
Price Target Change	$29.14
Price Target Change Top	$30.16

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	62,086,042%
Float Percent	100.05%
Shares Insiders	0.16%
Shares Institutions	74.66%
Shares Out	62,056,886
Shares Qo Q	-0.11%
Shares Yo Y	-0.85%
Short Ratio	6.97
Short Shares	3.67

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	303,514.25x
Bv Per Share	118.3
Ch1m	2.19
Ch1w	-0.17
Ch1y	25.56
Ch3m	-3.61
Ch3y	93.53
Ch5y	196.6
Ch6m	-8.48
Change	-0.65%
Change From Open	-0.62
Close	787.3
Days Gap	-0.03
Depreciation Amortization	8,675,250
Dollar Volume	277,126,741.8
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$1.3B
EBITDA	$1.3B
EPS	$22.49
F Score	2
Fiscal Year End	December
Founded	2,008
Graham Number	249.52184
Graham Upside	-68.1
Income Tax	$13.6M
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-19
Ma150	815.9
Ma150ch	-4.13%
Ma20	802
Ma20ch	-2.47%
Next Earnings Date	2026-07-30
Open	787.1
Optionable	Yes
Position In Range	29.13
Post Close	782.2
Postmarket Change Percent	1
Postmarket Price	$790
Pre Close	787.3
Price Date	2026-05-08
Price EBITDA	$37.25
Ptbv Ratio	6.96
Relative Volume	1.17x
Revenue	4,742,469,000x
Tax By Revenue	0.29x
Tax Rate	0.9%
Tr6m	-8.48%
Volume	354,305

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ARGX pay a dividend?

Capital-return profile for this ticker.

Performance

ARGX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ARGX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+74.7%

Float: +100.0% of shares outstanding

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ARGX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.0

Neutral momentum band

Price vs 200-day MA

-0.5%

50/200-day relationship not available

Beta (5Y)

-0.06

Less volatile than the market

Sharpe ratio

0.76

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ARGX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ARGX stock rating?

argenx SE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ARGX analysis?

The full report lives at /stocks/ARGX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ARGX?

The latest report frames ARGX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ARGX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.